FEATURE ARTICLES
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
- Understanding FDA's New National Priority Voucher Pilot Program
- AI-Assisted QMS: Bridging ISO/IEC 42001:2023 And ICH Q10 For Pharmaceutical Excellence
- Navigating FDA Regulatory Changes: Policy Shifts, Deregulation, Restructuring, And Future Oversight
- Understanding FDA's Draft Guidance: Composition Statements Of Ingredients In Labeling In NDAs And ANDAs
- How Is RIM Software Transforming Regulatory Compliance?
- Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet
- Scaling Up Manufacturing? Here's Why You Need A CMC Specialist
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1444551560-filling-aseptic-fill-finish-line]( "Streamlining Single-Use Assemblies In The Bulk-Fill Step Of Downstream Processing")
Streamlining Single-Use Assemblies In The Bulk-Fill Step Of Downstream ProcessingSingle-use (SU) systems and components are growing in demand as they offer minimal contamination risk. Review a standardized SU assembly for bulk-fill processing that aims to improve efficiency.
-
Combining Digital Platforms And QbD Principles7/9/2024
How can data and digitalization further improve pharmaceutical development and the continuous, quick, and efficient delivery of products?
-
Whitepaper: In Vivo Testing Of Nasal Dosage Forms5/7/2025
Explore how innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
-
A Scalable Single-Use Two-Step pDNA Purification Process3/6/2024
Evaluate the performance of a single-use two-step plasmid purification process, and see how it compares to the existing three-step purification method.
-
Quality: The Link Between Platform, Processes, And Patients2/18/2025
Quality management in healthcare and life sciences is crucial for optimizing patient health. Learn how modern quality management systems optimize patient outcomes, enhance safety, and drive operational efficiency.
-
Reducing Costs & Risks: A Pharma Guide To FTZ Subzones For U.S. Drug Manufacturing2/11/2025
Utilized wisely, FTZs and subzones can be tools for cost savings and can enable pharma companies to leverage the benefits of American manufacturing.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Seamless Process Transfer Using An In Silico Bioreactor Scaling Tool
- Propelling Glioblastoma Research: Orthotopic Model Solutions
- Mobile Advanced Therapies Facility
- Assessment Of Compound Toxicity Effects With High-Content Imaging
- Electron Activated Dissociation Workflow For Biotherapeutics Characterization
NEWSLETTER ARCHIVE
- 07.03.25 -- STREAM Edition: Solid Phase Versus Liquid Phase Peptide Synthesis
- 06.28.25 -- Product Inspection And Packaging Solutions For Pharma
- 06.27.25 -- ADCs Unleashed: Navigating Development Hurdles In Targeted Cancer Therapy
- 06.26.25 -- The 3 Phases Of QRM – An Inspector's View
- 06.26.25 -- STREAM Edition: Improving Peptide Yields Upstream
INDUSTRY NEWS
-
![White Tablets-GettyImages-172969989]( "Researchers Switch Up Paracetamol Production With Eco Method")
Researchers Switch Up Paracetamol Production With Eco MethodScientists at the University of Edinburgh’s Wallace Lab developed a method to produce paracetamol that can reduce environmental pollution and the industry’s reliance on fossil fuels
-
![FDA Approved stamp-GettyImages-2196512628]( "FDA Addresses U.S. Health Crisis With Voucher Program")
FDA Addresses U.S. Health Crisis With Voucher ProgramFDA Commissioner Marty Makary, M.D., M.P.H., tapped into his oncologist experience to launch a new FDA program designed to fast-track the time it takes for important drugs to receive approval and get to patients.
-
![Scientists working in lab-GettyImages-542935478]( "Lab Oversupply Is Pushing Leasing, Rent and Relocation Down")
Lab Oversupply Is Pushing Leasing, Rent and Relocation DownThe landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.
-
![US Food and Drug-GettyImages-2200850893]( "CDER's Director Set To Retire Amid FDA Leadership Shuffle")
CDER's Director Set To Retire Amid FDA Leadership ShuffleJacqueline Corrigan-Curay, M.D., J.D., announced plans to retire from her position as acting director of CDER, calling the decision "incredibly challenging." Corrigan-Curay is not alone in her decision to leave the FDA, with a number of leaders exiting the agency since January.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
CDMO BioSpring To Build New API Manufacturing Facility In Germany7/3/2025
Groundbreaking for the future: Together with Hesse’s Minister President Boris Rhein (CDU) and the Mayor of Offenbach, Dr. Felix Schwenke (SPD), BioSpring today inaugurated a new chapter in its company history on the Offenbach Innovation Campus. The company is building a new production facility that will set new standards and, once completed, become one of the world’s largest production sites for DNA- and RNA-based active pharmaceutical ingredients (APIs). This positions BioSpring as a key economic driver in Hesse and in one of the fastest-growing segments of the biotech industry.
-
InQuest Science Seeking Business Development Executive To Promote Software Technologies7/3/2025
Actively looking for an energetic, self starter to lead our outside sales team for our software company, specializing in the visual inspection industry. Identifying and securing new customers leads in a growing industry. We’re looking for a results-driven sales representative to actively seek out and engage customer prospects.
-
Riverarch Equity Partners Announce Acquisition Of Alconox By Portfolio Company TCP Analytical7/3/2025
Riverarch Equity Partners (“Riverarch”) and other investors, including Audax Strategic Capital, The Hillman Company, Lacy Diversified, and PPM America, together with their portfolio company TCP Analytical are pleased to announce the acquisition of Alconox, LLC (“Alconox” or the “Company”), a leading provider of branded laboratory cleaning solutions.
-
CAI And phData Announce Partnership To Accelerate AI-Driven Operational Readiness In Life Sciences7/3/2025
CAI, a global professional services firm renowned for Operational Readiness and Operational Excellence, today announced a strategic partnership with phData, a leader in data engineering and AI/ML solutions. Together, the companies will deliver intelligent, scalable technologies that help pharmaceutical and biotech manufacturers speed facility readiness, minimize operational delays, and maintain unwavering regulatory compliance.
-
Sandoz Breaks Announces Construction On New Drug Manufacturing Facility In Slovenia7/2/2025
Sandoz, the global leader in generic and biosimilar medicines, today announced the start of construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia.
